Complicated hereditary spastic paraplegia due to ATP13A2 mutations: what's in a name?

Affiliations

¹ Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
² Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
³ Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Comment

Susanne de Bot et al. Brain. 2017.

. 2017 Dec 1;140(12):e73.

doi: 10.1093/brain/awx280.

¹ Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
² Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
³ Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

No abstract available

Comment in

Reply: Complicated hereditary spastic paraplegia due to ATP13A2 mutations: what's in a name?
Schüle R. Schüle R. Brain. 2017 Dec 1;140(12):e74. doi: 10.1093/brain/awx282. Brain. 2017. PMID: 29112700 Free PMC article. No abstract available.

Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
Estrada-Cuzcano A, Martin S, Chamova T, Synofzik M, Timmann D, Holemans T, Andreeva A, Reichbauer J, De Rycke R, Chang DI, van Veen S, Samuel J, Schöls L, Pöppel T, Mollerup Sørensen D, Asselbergh B, Klein C, Zuchner S, Jordanova A, Vangheluwe P, Tournev I, Schüle R. Estrada-Cuzcano A, et al. Brain. 2017 Feb;140(2):287-305. doi: 10.1093/brain/aww307. Brain. 2017. PMID: 28137957 Free PMC article.